BioSpace News Archive

Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported financial results for the fourth quarter and full year ended December 31, 2021 as well as certain other business highlights.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a corporate update.

Illumina, Inc. announced that Carissa Rollins will join the company as Chief Information Officer on March 14, 2022.

Increasing prevalence of cancer and reproductive health disorders and evolution of cutting-edge next-generation sequencing (NGS) platforms are among the key factors expected to drive the global market revenue growth.

According to Precedence Research, the global clinical workflow solutions market size is expected to reach around US$ 23.99 billion by 2030 from valued at USD 8.26 billion in 2021 with a CAGR of 12.6% from 2021 to 2030.

The generic drugs market size is expected to hit USD 574.63 billion by 2027 from valued at USD 390.57 billion in 2020, with a CAGR of 5.59% during the forecast period 2021 to 2027.

According to Precedence Research, the global medical devices market is predicted to hit US$ 671.49 billion by 2027 and growing at a CAGR of 5.2% over the forecast period 2022 to 2027.

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced new findings by Daniel Snellings from the lab of Douglas Marchuk, PhD, at Duke University School of Medicine using single-cell DNA sequencing to identify genetic mechanisms leading to the development of cerebral cavernous malformations (CCMs).

At the annual meeting of the Healthcare Information and Management Systems Society, Konica Minolta Healthcare Americas, Inc., is highlighting new features of the Exa® Platform that automate common clinical and administrative tasks, enabling radiology departments and practices to enhance staff productivity, improve reimbursement and capture non-covered costs.

The healthcare sector is embracing the mobile imaging technology for its excellent contribution to patient care.